PULMOTRACK,MODEL 1010

K980878 · Karmel Medical Acoustic Technologies , Ltd. · BZM · Dec 28, 1998 · Anesthesiology

Device Facts

• Record ID: K980878
• Device Name: PULMOTRACK,MODEL 1010
• Applicant: Karmel Medical Acoustic Technologies , Ltd.
• Product Code: BZM · Anesthesiology
• Decision Date: Dec 28, 1998
• Decision: SESE
• Submission Type: Traditional
• Regulation: 21 CFR 868.1900
• Device Class: Class 2

Intended Use

The PulmoTrack Model 1010 is intended for the analysis, interpretation and documentation of lung sounds. The PulmoTrack Model 1010 is indicated for use by or under the supervision of a physician while carrying out a provocation test, administering a bronchodilator or performing a physical examination in a pulmonary function testing environment when there is a need to perform an acoustic pulmonary function measurement that quantifies the presence of wheezing. It is also indicated when there is a need to listen to amplified and filtered breath sounds.

Device Story

PulmoTrack Model 1010 is a computer-based electronic stethoscope system. It utilizes up to five contact sensors placed on the trachea and thorax to acquire pulmonary sounds. The device amplifies, filters, and records these acoustic signals. It performs analysis to quantify the presence of wheezing. Outputs include high-fidelity audio, visual displays, and printed reports. Used in pulmonary function testing environments by physicians or under their supervision to assist in physical examinations, provocation tests, or bronchodilator administration. The system provides clinicians with objective acoustic data to aid in the assessment of lung sounds and wheeze detection.

Technological Characteristics

Computer-based electronic stethoscope; utilizes up to five contact sensors for simultaneous signal acquisition; signal processing includes amplification and filtering; provides visual display and printed reports; system architecture integrates acoustic sensing with computer-based analysis.

Indications for Use

Indicated for patients requiring acoustic pulmonary function measurement to quantify wheezing or auscultation of amplified/filtered breath sounds during provocation tests, bronchodilator administration, or physical exams in pulmonary function testing environments. Use by or under physician supervision.

Regulatory Classification

Identification

A diagnostic pulmonary-function interpretation calculator is a device that interprets pulmonary study data to determine clinical significance of pulmonary-function values.

Predicate Devices

• Littmann Brand Electronic Stethoscope
• Pulmonary Function Test Laboratory, System1010

Submission Summary (Full Text)

{0}------------------------------------------------

# IV. SUMMARY OF SAFETY AND EFFECTIVENESS

This summary of safety and effectiveness information is being submitted in accordance with the requirements of the SMDA 1990 and 21 CFR 807.92.

# Submitter:

Karmel Medical Acoustic Technologies Ltd., POB 389, Tirat Hacarmel,39554, Israel

Tel: [phone] Fax: [phone]

Name of the Device: PulmoTrack Model 1010

Predicate Devices: The PulmoTrack Model 1010 is substantially equivalent to the combination of the Littmann Brand Electronic Stethoscope and the Pulmonary Function Test Laboratory, System1010.

## Description of the Device:

The PulmoTrack is a computer based electronic stethoscope that utilizes up to five contact sensors simultaneously to acquire, amplify, filter, record and analyze pulmonary sounds from the trachea and thorax and provides high fidelity audio outputs, visual displays and printed reports.

{1}------------------------------------------------

Image /page/1/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo is a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" arranged around the top half of the circle. Inside the circle is an abstract symbol that resembles a stylized caduceus or a family of three people.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

DEC 28 1998

Dr. Charles S. Irving Karmel Medical Acoustic Technologies Ltd. 9 Ezel Street, P.O. Box 389 Tirat Hacarmel ISRAEL 39554

Re: K980878 PulmoTrack™ Model 1010 Regulatory Class: II (two) Product Code: 73 BZM October 28, 1998 Dated: Received: October 29, 1998

Dear Dr. Irving:

We have reviewed your Section 510(k) notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to leqally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

If your device is classified (see above) into either class II (Special Controls) or class III (Premarket Approval), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 895. A substantially equivalent determination assumes compliance with the Current Good Manufacturing Practice requirements, as set forth in the Quality System Regulation (QS) for Medical Devices: General regulation (21 CFR Part 820) and that, through periodic QS inspections, the Food and Drug Administration (FDA) will verify such assumptions. Failure to comply with the GMP regulation may result in regulatory action. In addition, FDA may publish further announcements concerning your device in the Federal Register. Please note: this response to your premarket notification submission does not affect any obligation you might have under sections 531 through 542 of the Act for devices under the Electronic Product Radiation Control provisions, or other Federal laws or regulations.

{2}------------------------------------------------

Page 2 - Dr. Charles S. Irving

This letter will allow you to begin marketing your device as described in your 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.

If you desire specific advice for your device on our labeling requlation (21 CFR Part 801 and additionally 809.10 for in vitro diagnostic devices), please contact the Office of Compliance at [phone]. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at [phone]. Also, please note the regulation entitled, "Misbranding by reference to premarket notification"(21 CFR 807.97). Other qeneral information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers Assistance at its toll-free number [phone] or [phone], or at its internet address "http://www.fda.gov/cdrh/dsma/dsmamain.html".

Sincerely yours,

Thomas J. Callahan, Ph.D.

Director Division of Cardiovascular, Respiratory, and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health

Enclosure

{3}------------------------------------------------

## INDICATIONS FOR USE

| 510(k) Number (if known): | K980878 |
|---------------------------|---------|
|---------------------------|---------|

Device Name:

PulmoTrack™ Model 1010

## Indications For Use:

The PulmoTrack Model 1010 is intended for the analysis, interpretation and documentation of lung sounds.

The PulmoTrack Model 1010 is indicated for use by or under the supervision of a physician while carrying out a provocation test, administering a bronchodilator or performing a physical examination in a pulmonary function testing environment when there is a need to perform an acoustic pulmonary function measurement that quantifies the presence of wheezing. It is also indicated when there is a need to listen to amplified and filtered breath sounds.

(PLEASE DO NOT WRITE BELOW THIS LINE -CONTINUE ON ANOTHER PAGE IF NEEDED) Concurrence of CDRH, Office of Device Evaluation (ODE)

Marla Kramer

(Division Sign-Off) Division of Cardiovascular, Respiratory, and Neurological Devices

510(k) Number R920876

Prescription Use (Per 21 CFR 801.109)

OR

Over the Counter Use